Compare HCA Health Inc (HCA) vs Lucid Group Inc (LCID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Lucid Group Inc — how do they compare? HCA Health Inc trades at $443.69 (market cap $95.08B), while Lucid Group Inc trades at $3.84 (market cap $1.53B). The key difference: HCA Health Inc is far larger — about 62.1× Lucid Group Inc's market cap, and HCA Health Inc pays a 0.71% dividend while Lucid Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Lucid Group Inc for 45 Days on average.
| HCA | LCID | |
|---|---|---|
Market Cap | $95.08B | $1.53B |
Volume | 998,787 | 12,739,758 |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $21.92 |
52-Week Low | $361.32 | $3.82 |
Typical Hold Time | 76 Days | 45 Days |
Enterprise Value | $145.62B | $4.43B |
Dividend Yield | 0.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $445.01, up 2.96% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $75.6B in 2025, with net income of $6.78B, and the stock trades at a P/E of 14.73. Analyst consensus is a Buy with a $461.12 price target, though ongoing legal investigations pose a headwind.
The outlook remains positive given solid demand and cost controls, but risks include payer-mix pressure and high debt levels. Upside potential exists if earnings growth continues, but investors should monitor legal developments and interest rate impacts on the leveraged balance sheet.
Lucid Group (LCID) trades at $3.89, down 6.49% in the last session, reflecting ongoing investor concerns about the company's financial performance. The stock shows bearish technical signals with negative moving averages and faces fundamental challenges including consecutive quarterly earnings misses, negative profit margins of -249.21%, and substantial cash burn. Recent developments include strategic partnerships for autonomous vehicle deployment in Europe but also product delays and cost-cutting initiatives targeting $1.4 billion in savings.
The outlook remains challenging with significant execution risks and negative cash flow trends. While analyst consensus suggests potential upside to a $7.60 price target, the high proportion of hold ratings (66.67%) indicates caution. Key risks include continued cash burn, competitive pressures in the EV market, and execution of turnaround plans. The company's survival depends on successful cost management and timely product launches.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Lucid Group Inc
Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It is a vertically integrated company that designs, engineers, and builds electric vehicles, EV powertrains, and battery systems in-house using our own equipment and factory.
Read more on LCID →
